Tectonic Therapeutic Income Statement (2017-2026) | TECX

Income Statement Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter)
3.64M3.64M3.64M0.00M0.00M0.00M0.00M3.69M3.71M3.72M3.74M2.92M14.74M8.49M18.67M18.71M18.71M18.74M18.83M19.55M
Operating items
Research & Development (Quarter)
23.04M19.00M19.25M18.88M15.92M18.14M17.33M8.77M8.13M7.19M10.82M7.07M14.32M9.16M13.04M17.18M16.93M16.34M20.87M18.05M
Selling, General & Administrative (Quarter)
9.58M8.96M10.16M8.90M7.07M7.12M7.89M1.86M1.98M2.18M2.15M4.35M5.32M4.83M5.26M5.15M4.96M5.17M6.43M6.17M
Other Operating Expenses (Quarter)
83.74M
Operating Expenses (Quarter)
32.62M27.96M29.42M27.77M22.98M25.26M25.22M10.63M10.11M9.37M12.97M11.42M19.64M13.99M18.30M22.33M21.89M21.52M27.30M24.22M
Operating Income (Quarter)
-32.62M-27.96M-29.42M-27.77M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M-24.22M
EBIT (Quarter)
-32.62M-27.96M-29.42M-27.77M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M-24.22M
Non-operating items
Interest & Investment Income (Quarter)
0.00M-0.24M-0.37M-0.28M0.11M0.24M0.25M0.22M0.10M0.13M0.26M0.32M1.95M1.74M2.44M3.39M2.90M2.56M2.18M2.02M
Other Non Operating Income (Quarter)
0.01M-0.04M0.01M-0.10M0.01M-0.01M-0.00M0.41M-0.40M-0.01M-0.01M-0.10M-0.03M-0.05M-0.03M4.24M-0.11M-0.01M
Non Operating Income (Quarter)
0.01M-0.27M-0.41M-0.28M0.02M0.22M0.26M0.18M0.06M1.50M-2.25M-1.25M1.92M1.62M2.39M3.32M2.85M2.54M2.06M2.01M
Net income details
EBT (Quarter)
-32.62M-28.41M-31.12M-29.30M-24.02M-25.82M-25.97M-10.64M-11.09M-9.28M-13.23M-12.67M-17.72M-9.87M-16.00M-19.01M-19.04M-18.97M-53.80M-22.21M
Tax Provisions (Quarter)
0.98M0.25M0.08M
Profit After Tax (Quarter)
-32.61M-28.23M-29.83M-28.05M-22.97M-25.03M-14.45M-10.46M-10.05M-7.85M-15.22M-12.67M-17.72M-12.39M-15.91M-19.98M-19.04M-19.27M-25.24M-22.30M
Income from Non-Controlling Interests (Quarter)
10.46M10.05M7.88M15.27M12.68M17.73M12.30M15.91M20.04M19.06M19.25M25.20M22.29M
Income from Continuing Operations (Quarter)
-32.62M-28.41M-31.12M-29.30M-24.02M-25.82M-25.97M-10.64M-11.09M-9.28M-13.23M-12.67M-17.72M-9.87M-16.00M-19.98M-19.04M-19.23M-53.80M-22.29M
Consolidated Net Income (Quarter)
-32.62M-28.41M-31.12M-29.30M-24.02M-25.82M-25.97M-10.64M-11.09M-9.28M-13.23M-12.67M-17.72M-9.87M-16.00M-19.98M-19.04M-19.23M-53.80M-22.29M
Income towards Parent Company (Quarter)
-32.62M-28.41M-31.12M-29.30M-24.02M-25.82M-25.97M-10.64M-11.09M-9.28M-13.23M-12.67M-17.72M-9.87M-16.00M-19.98M-19.04M-19.23M-53.80M-22.29M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-32.62M-28.41M-31.12M-28.05M-22.97M-25.03M-25.97M67.48M-10.05M-7.87M-15.22M-12.67M-17.72M-12.37M-15.91M-19.98M-19.04M-19.23M-25.24M-22.29M
Additional items
EPS (Basic) (Quarter)
-8.97-7.96-8.55-0.01M-0.01M-0.01M-0.01M18.35-2.71-2.13-4.08-4.34-1.20-1.46-0.93-1.07-1.02-1.05-1.34-1.18
EPS (Diluted) (Quarter)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M18.29-2.71-2.12-4.08-4.34-1.20-1.46-0.93-1.07-1.02-1.05-1.34-1.18
Shares Outstanding (Quarter)
3.64M3.57M3.64M0.00M0.00M0.00M0.00M3.68M3.71M3.69M3.73M2.92M14.73M8.49M17.16M18.68M18.71M18.32M18.77M18.96M
Shares Outstanding (Diluted) (Quarter)
0.00M0.00M0.00M0.00M0.00M0.00M0.00M3.69M3.71M3.71M3.73M2.92M14.73M8.49M17.16M18.68M18.71M18.32M18.77M18.96M
EBITDA (Quarter)
-32.62M-27.96M-29.42M-27.77M-22.98M-25.26M-25.22M-10.63M-10.11M-9.37M-12.97M-11.42M-19.64M-13.99M-18.30M-22.33M-21.89M-21.52M-27.30M-24.22M
Interest Expenses (Quarter)
0.20M1.33M1.25M1.15M0.81M0.99M0.23M1.07M0.03M0.52M9.83M33.50M0.02M0.15M0.02M5.30M0.01M28.68M35.03M
Tax Rate (Quarter)
-5.13-1.34-0.35